| [1] |
国家心血管病中心，中国心血管健康与疾病报告编写组，胡盛寿.中国心血管健康与疾病报告2023概要[J].中国循环杂志，2024,39(7):625-660.
|
| [2] |
Berg G, Miksztowicz V, Morales C, et al. Epicardial adipose tissue in cardiovascular disease[J]. Adv Exp Med Biol, 2019, 1127:131-143.
|
| [3] |
van Woerden G, van Veldhuisen DJ, Westenbrink BD, et al. Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives[J]. Eur J Heart Fail, 2022, 24(12):2238-2250.
|
| [4] |
Madonna R, Massaro M, Scoditti E, et al. The epicardial adipose tissue and the coronary arteries: dangerous liaisons[J]. Cardiovasc Res, 2019, 115(6):1013-1025.
|
| [5] |
Ansaldo AM, Montecucco F, Sahebkar A, et al. Epicardial adipose tissue and cardiovascular diseases[J]. Int J Cardiol, 2019, 278:254-260.
|
| [6] |
王钊，刁树玲.心外膜脂肪组织在心血管疾病中研究进展[J].中国医学创新，2023,20(31):166-170.
|
| [7] |
Kanta Chechi, Jinchu Vijay, Pierre Voisine, et al. UCP1 expression-associated gene signatures of human epicardial adipose tissue[J]. JCI insight, 2019, 4(8):e123618.
|
| [8] |
Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes[J]. Front Physiol, 2020, 10:1607.
|
| [9] |
Sousa JA, Mendonça MI, Serrão M, et al. Epicardial adipose tissue: The genetics behind an emerging cardiovascular risk marker[J]. Clin Med Insights Cardiol, 2021, 15:11795468211029244.
|
| [10] |
Kim SA, Kim MN, Shim WJ, et al. Epicardial adipose tissue is related to cardiac function in elderly women, but not in men[J]. Nutr Metab Cardiovasc Dis, 2017, 27(1):41-47.
|
| [11] |
Atilla E. Adipose tissue hypoxia in obesity: Clinical reappraisal of hypoxia hypothesis[J]. Adv Exp Med Boil, 2024, 1460:329-356.
|
| [12] |
Corvera S, Solivan-Rivera J, Loureiro ZY. Angiogenesis in adipose tissue and obesity[J]. Angiogenesis, 2022, 25(4):439-453.
|
| [13] |
Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization[J]. J Clin Invest, 2007, 117:175-184.
|
| [14] |
李星，任志鹏. CT心肌灌注和冠状动脉CT血管成像测量心外膜脂肪体积及其相关值与冠心病的相关性研究[J].转化医学杂志，2024,13(8):1210-1214.
|
| [15] |
安景景，靳通通，闫静，等.超声心外膜脂肪厚度联合心肌分层应变参数预测冠心病患者冠脉狭窄程度[J].西部医学，2024,36(3):454-459.
|
| [16] |
Hirata Y, Tabata M, Kurobe H, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue[J]. J Am Coll Cardiol, 2011, 58(3):248-255.
|
| [17] |
薛亚军，黄文华，杜雅彦，等.冠心病心外膜脂肪组织中KLF7促进炎症反应及脂肪分化成熟[J].安徽医科大学学报，2022,57(2):197-202.
|
| [18] |
Fan WJ, Si YQ, Xing EH, et al. Human epicardial adipose tissue inflammation correlates with coronary artery disease[J]. Cytokine, 2023, 162:156119.
|
| [19] |
Jemtel THL, Samson R, Ayinapudi K, et al. Epicardial adipose tissue and cardiovascular disease[J]. Curr Hypertens Rep, 2019, 21(5):36.
|
| [20] |
Karampetsou N, Alexopoulos L, Minia A, et al. Epicardial adipose tissue as an independent cardiometabolic risk factor for coronary artery disease[J]. Cureus, 2022, 14(6): e25578.
|
| [21] |
Bornachea O, Vea A, Llorente-Cortes V. Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases[J]. Clin Investig Arterioscler, 2018, 30(5):230-239.
|
| [22] |
McLaughlin T, Schnittger I, Nagy A, et al. Relationship between coronary atheroma, epicardial adipose tissue inflammation, and adipocyte differentiation across the human myocardial bridge[J]. J Am Heart Assoc, 2021, 10(22):e021003.
|
| [23] |
Cho-Kai W, Hao-Yuan T, Mao-Yuan MS, et al. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients[J]. J Clin Lipidol, 2017, 11(6):1421-1431.
|
| [24] |
Nalliah CJ, Bell JR, Raaijmakers AJA, et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality[J]. J Am Coll Cardiol, 2020, 76:1197-1211.
|
| [25] |
Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Failure Society of America[J]. J Am Coll Cardiol, 2017, 70:776-803.
|
| [26] |
van Woerden G, Gorter TM, Westenbrink BD, et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail, 2018, 20:1559-1566.
|
| [27] |
Crum Y, Hoendermis ES, van Veldhuisen DJ, et al. Epicardial adipose tissue and pericardial constraint in heart failure with preserved ejection fraction[J]. ESC Heart Fail, 2024, 11(3):1698-1706.
|
| [28] |
van Woerden G, van Veldhuisen DJ, Gorter TM, et al. Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction[J]. Clin Cardiol, 2021, 44:987-993.
|
| [29] |
Arshi B, Aliahmad HA, Ikram MA, et al. Epicardial fat volume, cardic function, and incident heart failure: the rotterdam study[J]. J Am Heart Assoc, 2023, 12(1):e026197.
|
| [30] |
Gorter TM, van Woerden G, Rienstra M, et al. Epicardial adipose tissue and invasive hemodynamics in heart failure with preserved ejection fraction[J]. JACC Heart Fail, 2020, 8:667-676.
|
| [31] |
Zhao L, Guo Z, Wang P, et al. Proteomics of epicardial adipose tissue in patients with heart failure[J]. J Cell Mol Med, 2020, 4:511-520.
|
| [32] |
Cho DH, Park SM. Epicardial adipose tissue and heart failure, friend or foe?[J]. Diabetes Metab J, 2024, 48(3):373-384.
|
| [33] |
Nalliah CJ, Bell JR, Raaijmakers AJA, et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality[J]. J Am Coll Cardiol, 2020, 76(10):1197-1211.
|
| [34] |
Wang Q, Xi W, Yin L, et al. Human epicardial adipose tissue cTGF expression is an independent risk factor for atrial fibrillation and highly associated with atrial fibrosis[J]. Sci Rep, 2018, 8:3585.
|
| [35] |
Ernault AC, Verkerk AO, Bayer JD, et al. Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling[J]. Heart Rhythm, 2022, 19(9):1461-1470.
|
| [36] |
Fan YB, Huang SS, Li SH, et al. The adipose-neural axis is involved in epicardial adipose tissue-related cardiac arrhythmias[J]. Cell Rep Med, 2024, 5(5):101559.
|
| [37] |
Huber AT, Fankhauser S, Chollet L, et al. The relationship between enhancing left atrial adipose tissue at ct and recurrent atrial fibrillation[J]. Radiology, 2022, 305(1):212644.
|
| [38] |
van Woerden G, van Veldhuisen DJ, Gorter TM, et al. The value of echocardiographic measurement of epicardial adipose tissue in heart failure patients[J]. ESC Heart Fail, 2022, 9:953-957.
|
| [39] |
van Woerden G, van Veldhuisen DJ, Gorter TM, et al. Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid-range and preserved ejection fraction[J]. Clin Cardiol, 2021, 44(7):987-993.
|
| [40] |
Cho-Kai W, Jen-Kuang L, Jung-Chi H, et al. Myocardial adipose deposition and the development of heart failure with preserved ejection fraction[J]. Eur J Heart Fail, 2020, 22(3):445-54.
|
| [41] |
Liu ZH, Wang SJ, Wang YQ, et al. Association of epicardial adipose tissue attenuation with coronary atherosclerosis in patients with a high risk of coronary artery disease[J]. Atherosclerosis, 2019, 284:230-236.
|
| [42] |
Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): A post-hoc analysis of prospective outcome data[J]. Lancet, 2018, 392(10151):929-939.
|
| [43] |
Iacobellis G, Baroni MG. Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat[J]. J Endocrinol Invest, 2022, 45:489-95.
|
| [44] |
Brown E, Heerspink HJL, Cuthbertson DJ, et al. SGLT2 inhibitors and GLP-1 receptor agonists: Established and emerging indications[J]. Lancet, 2021, 398(10296):262-276.
|
| [45] |
Gianluca I, Gra-Menendez S. Effects of dapagliflozin on epicardial fat thickness in patients with type 2 diabetes and obesity[J]. Obesity, 2020, 28:1068-1074.
|
| [46] |
Ferrannini E, Mark M, Mayoux E. CV protection in the EMPA-REG OUTCOME trial: A "thrifty substrate" hypothesis[J]. Diabetes Care, 2016, 39(7):1108-1114.
|
| [47] |
Kim SR, Sang-Guk L, KimSH, et al. SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease[J]. Nat Commun, 2020, 11(1):2127.
|
| [48] |
Byrne NJ, Soni S, Takahara S, et al. Chronically elevating circulating ketones can reduce cardiac inflammation and blunt the development of heart failure[J]. Circ Heart Fail, 2020, 13(6):e006573.
|
| [49] |
刘美，冯雪茹，刘梅林.达格列净对冠心病合并2型糖尿病患者心外膜脂肪衰减值的影响[J].中国临床药理学杂志，2024,40(9):1243-1247.
|
| [50] |
Gianluca I, Fricke ACV. Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity[J]. J Endocr Soc, 2020, 4(4):bvz042.
|
| [51] |
Dozio E, Vianello E, Malavazos AE, et al. Epicardial adipose tissue GLP-1receptor is associated with genes involved in fatty acid oxidation and white- to-brown fat differentiation: A target to modulate cardiovascular risk?[J]. Int J Cardiol, 2019, 292:218-224.
|
| [52] |
Fainberg HP, Birtwistle M, Alagal R, et al. Transcriptional analysis of adipose tissue during development reveals depot-specific responsiveness to maternal dietary supplementation[J]. Sci Rep, 2018, 8(1):9628.
|
| [53] |
Cypess AM, Weiner LS, Roberts-Toler C, et al. Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist[J]. Cell Metab, 2015, 21(1):33-38.
|